Genmab A+s

Jorgen Petersen

Paul Parren

Haichun Huang

Ole Baadsgaard

Jan G J Van De Winkel

Jessica Teeling

Debra Hudson

Janine Schuurman

Edward L Halk

Arnout F Gerritsen

Denise Leah Williams

Marcus A Van Dijk

Catharina Emanuele Gerarda Havenith

Ole D M Sc Baadsgaard

Jan GJ Van De Winkel

Ole DM Sc Baadsgaard

Jessica Woodmill Cottage Teeling

Marcus Antonius Van Dijk

Isolated human monoclonal antibodies which bind to IL-8 (e.g., human IL-8) are disclosed. The human antibodies can be produced in a hybridoma, transfectoma or in a non-human transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies, non-human transgenic animals, hybridomas, and transfectomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.

Methods of treating cancer with human monoclonal antibodies against interleukin 8

Isolated human monoclonal antibodies which specifically bind to human EGFR, and related antibody-based compositions and molecules, are disclosed. The human antibodies can be produced by a transfectoma or in a non-human transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies, non-human transgenic animals and hybridomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.

Human monoclonal antibodies to epidermal growth factor receptor (EGFR)

Isolated human monoclonal antibodies which bind to and inhibit human CD25, and related antibody-based compositions and molecules, are disclosed. The human antibodies can be produced by a hybridoma, a transfectoma or in a nonhuman transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies, nonhuman transgenic animals, hybridomas and transfectomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.

Human monoclonal antibodies against CD25

Human monoclonal antibodies against interleukin 8 (IL-8)

Growing community of inventors

Rungsted Kyst, Denmark

Jorgen Petersen